Cargando…
Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378856/ https://www.ncbi.nlm.nih.gov/pubmed/28396772 http://dx.doi.org/10.1002/ccr3.872 |
_version_ | 1782519493887524864 |
---|---|
author | Otsuka, Yasuyuki Nishikori, Momoko Kitano, Toshiyuki Oka, Tomomi Ishikawa, Takayuki Haga, Hironori Takaori‐Kondo, Akifumi |
author_facet | Otsuka, Yasuyuki Nishikori, Momoko Kitano, Toshiyuki Oka, Tomomi Ishikawa, Takayuki Haga, Hironori Takaori‐Kondo, Akifumi |
author_sort | Otsuka, Yasuyuki |
collection | PubMed |
description | We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases. |
format | Online Article Text |
id | pubmed-5378856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53788562017-04-10 Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years Otsuka, Yasuyuki Nishikori, Momoko Kitano, Toshiyuki Oka, Tomomi Ishikawa, Takayuki Haga, Hironori Takaori‐Kondo, Akifumi Clin Case Rep Case Reports We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases. John Wiley and Sons Inc. 2017-03-02 /pmc/articles/PMC5378856/ /pubmed/28396772 http://dx.doi.org/10.1002/ccr3.872 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Otsuka, Yasuyuki Nishikori, Momoko Kitano, Toshiyuki Oka, Tomomi Ishikawa, Takayuki Haga, Hironori Takaori‐Kondo, Akifumi Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title | Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title_full | Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title_fullStr | Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title_full_unstemmed | Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title_short | Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
title_sort | persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378856/ https://www.ncbi.nlm.nih.gov/pubmed/28396772 http://dx.doi.org/10.1002/ccr3.872 |
work_keys_str_mv | AT otsukayasuyuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT nishikorimomoko persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT kitanotoshiyuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT okatomomi persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT ishikawatakayuki persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT hagahironori persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years AT takaorikondoakifumi persistenceofat1114positivecloneinapatientwithmantlecelllymphomafor20years |